Valuation North China Pharmaceutical Company.Ltd

Stocks

End-of-day quote Shanghai S.E. 15/09/2026			5-day change	1st Jan Change
4.590 ^CNY	-6.71%		-2.55%	-17.00%

08-21	North China Pharmaceutical Company.Ltd Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-04	North China Pharmaceutical's Eight Products Win Preliminary Bids Under Government Drug Procurement Program	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	16,781	20,452	10,981	9,780	8,870	9,488
Change	-	21.87%	-46.31%	-10.94%	-9.3%	6.96%
Enterprise Value (EV) ¹	25,126	28,923	20,346	19,939	18,660	19,162
Change	-	15.11%	-29.65%	-2%	-6.41%	2.69%
P/E	172x	1,084x	-15.9x	1,900x	69.9x	51.7x
PBR	2.74x	3.36x	2.07x	1.84x	1.65x	1.72x
PEG	-	-13.3x	0x	-19x	0x	1.2x
Capitalization / Revenue	1.46x	1.97x	1.05x	0.97x	0.9x	1.03x
EV / Revenue	2.19x	2.79x	1.94x	1.97x	1.89x	2.07x
EV / EBITDA	20.8x	23.7x	15.2x	15.7x	12.9x	12.6x
EV / EBIT	42x	48.2x	32.1x	37.2x	28.3x	30.6x
EV / FCF	-30.9x	-32x	112x	128x	49.1x	35.2x
FCF Yield	-3.24%	-3.12%	0.89%	0.78%	2.03%	2.84%
Dividend per Share ²	0.03	0.06	-	0.01	0.03	0.035
Rate of return	0.29%	0.5%	-	0.18%	0.58%	0.63%
EPS ²	0.06	0.011	-0.402	0.003	0.074	0.107
Distribution rate	50%	545%	-	333%	40.5%	32.7%
Net sales ¹	11,493	10,385	10,500	10,120	9,870	9,242
EBITDA ¹	1,209	1,221	1,343	1,272	1,447	1,517
EBIT ¹	597.9	600.1	634.8	536.4	658.9	627.2
Net income ¹	97.32	18.73	-689.2	4.89	127	183.1
Net Debt ¹	8,345	8,472	9,366	10,159	9,790	9,674
Reference price ²	10.290	11.920	6.400	5.700	5.170	5.530
Nbr of stocks (in thousands)	1,630,805	1,715,730	1,715,730	1,715,730	1,715,730	1,715,730
Announcement Date	4/28/21 A	4/27/22 A	4/21/23 A	3/29/24 A	3/27/25 A	4/17/26 A

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NORTH CHINA PHARMACEUTICAL COMPANY.LTD	-	-	-	-	1.26B
ELI LILLY AND COMPANY	32.41x	11.77x	23.88x	0.61%	1,015B
JOHNSON & JOHNSON	29.62x	6.59x	18.45x	2.02%	642B
ABBVIE INC.	33.52x	7.76x	16.03x	2.62%	463B
ROCHE HOLDING AG	19.65x	4.78x	11.85x	2.77%	353B
NOVARTIS AG	19.69x	5.14x	12.76x	3.13%	265B
ASTRAZENECA PLC	21.05x	4.32x	12.35x	2.04%	254B
AMGEN INC.	24.13x	6.36x	11.33x	2.64%	206B
NOVO NORDISK A/S	12.48x	4.54x	9.49x	4.03%	191B
GILEAD SCIENCES, INC.	-44.28x	6.46x	25.23x	2.25%	182B
Average	16.47x	6.41x	15.71x	2.46%	357.15B
Weighted average by Cap.	23.59x	7.64x	17.62x	2.01%